Physician

Ramin Seyed Berenji, M.D.

According to 2025 Medicare claims, Ramin Berenji, M.D. (NPI: 1063497691) practices nephrology in the El Centro, CA market, with the plurality of this provider's patient population coming from Imperial, CA. This provider's primary affiliated billing organization is BALBOA NEPHROLOGY MEDICAL GROUP, INC. (NPI: 1316997505; TIN: 952848091) and primary practice location at 92243-3623.

Berenji's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 451 traditional Medicare patients, billed 2,495 HCPCS/CPT codes, and received $236,100 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,835 prescription claims across 330 beneficiaries totaling $711,571 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 383 claims. Open Payments data shows 27 records totaling $36,589. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $3,225 to $2,445.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	821	13,081	$329,347
2016	762	5,078	$335,605
2017	744	4,653	$331,033
2018	762	4,870	$378,629
2019	725	4,871	$417,275
2020	785	3,289	$419,437
2021	665	2,673	$411,656
2022	485	1,812	$242,488
2023	412	1,523	$200,948
2024	451	2,495	$236,100

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	380	4,322	$841,868
2016	370	4,208	$971,579
2017	422	4,383	$990,619
2018	428	4,362	$893,345
2019	437	4,876	$1,212,950
2020	469	5,868	$1,574,376
2021	456	5,386	$1,608,749
2022	391	3,872	$1,522,796
2023	328	2,748	$1,169,840
2024	330	2,835	$711,571

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	44	758	$73,769
2016	104	906	$74,928
2017	112	1,102	$90,331
2018	94	856	$64,641
2019	75	850	$58,848
2020	72	837	$51,529
2021	56	602	$30,414
2022	N/R	436	$18,636
2023	N/R	348	$15,759
2024	N/R	383	$9,632

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	65	72	$134
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	90	221	$93
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	115	288	$62
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	192	579	$52
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	210	631	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	53	2,970	$265,128
Veltassa	Patiromer Calcium Sorbitex	45	1,694	$54,940
Vascepa	Icosapent Ethyl	122	4,260	$51,319
Farxiga	Dapagliflozin Propanediol	65	2,740	$46,610
Tradjenta	Linagliptin	52	2,865	$43,274

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	37	$2,605
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	93	$2,052
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	89	$1,769
J7500	Azathioprine, oral, 50 mg	N	N/R	11	$1,326
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	73	$1,282

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$2,668	CSL Behring
Research Payments	Reported research-related payment or transfer-of-value amount.	10	$33,922	CSL Behring
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ramin Seyed Berenji, M.D.?

Tedicare shows public-source Medicare data for Ramin Seyed Berenji, M.D. (NPI 1063497691), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ramin Seyed Berenji, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ramin Seyed Berenji, M.D.?

Ramin Seyed Berenji, M.D. is linked to BALBOA NEPHROLOGY MEDICAL GROUP, INC. (billing NPI 1316997505) in the available physician profile data.

Does Ramin Seyed Berenji, M.D. have Open Payments data?

Ramin Seyed Berenji, M.D. has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.